These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33895715)

  • 1. Economic costs of terminal care for selected non-communicable diseases from a healthcare perspective: a review of mortality records from a tertiary hospital in Nigeria.
    Olumide AO; Shmueli A; Omotade OO; Adebayo ES; Alonge TO; Ogun GO
    BMJ Open; 2021 Apr; 11(4):e044969. PubMed ID: 33895715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic costs of cigarette smoking among adolescents in Nigeria.
    Olumide AO; Shmueli A; Adebayo ES; Omotade OO
    Z Gesundh Wiss; 2022; 30(7):1701-1712. PubMed ID: 35789784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of heart failure: investigating outpatient and inpatient costs in Abeokuta, Southwest Nigeria.
    Ogah OS; Stewart S; Onwujekwe OE; Falase AO; Adebayo SO; Olunuga T; Sliwa K
    PLoS One; 2014; 9(11):e113032. PubMed ID: 25415310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of illness of non-communicable diseases in private and public health facilities in Nigeria: a qualitative and quantitative approach.
    Ipinnimo TM; Elegbede OE; Durowade KA; Adewoye KR; Ibirongbe DO; Ajayi PO; Sanni TA; Fatunla OAT; Ipinnimo MT; Ibikunle AI
    Pan Afr Med J; 2023; 44():6. PubMed ID: 36818035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of morbidity and mortality among patients admitted in a tertiary hospital in southern Nigeria: A 6 year evaluation.
    Okoroiwu HU; Uchendu KI; Essien RA
    PLoS One; 2020; 15(8):e0237313. PubMed ID: 32841255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of non-communicable diseases on households in Nigeria: evidence from the Nigeria living standard survey 2018-19.
    Odunyemi A; Rahman T; Alam K
    BMC Public Health; 2023 Aug; 23(1):1563. PubMed ID: 37592334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
    Ezenduka C; Ichoku H; Ochonma O
    J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis.
    Santos AC; Willumsen J; Meheus F; Ilbawi A; Bull FC
    Lancet Glob Health; 2023 Jan; 11(1):e32-e39. PubMed ID: 36480931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of primary health care costs and resource requirements in Kaduna and Kano, Nigeria.
    Ogundeji Y; Abubakar H; Ezeh U; Hussaini T; Kamau N; Love E; Muñoz R; Ongboche P; Opuni M; Walker DG; Gilmartin C
    Front Public Health; 2023; 11():1226145. PubMed ID: 38239799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria.
    Umar NA; Abubakar I; Fordham R; Bachmann M
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):835-40. PubMed ID: 22613686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to health in women of reproductive age living with or at risk of non-communicable diseases in Nigeria: a Photovoice study.
    Etuk I; Iwuala A; Njoku K; Olagbegi B; Ogboye A; Akpakli JK; Okoli U; Hill K; Adetiloye O; Imosemi D; Omoera V; Oludara F; Ekong I; Alabi O; Mobisson N
    BMC Womens Health; 2023 Jan; 23(1):3. PubMed ID: 36593476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease and age pattern of hospitalisation and associated costs in India: 1995-2014.
    Kastor A; Mohanty SK
    BMJ Open; 2018 Jan; 8(1):e016990. PubMed ID: 29371266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
    Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
    PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to healthcare services for people with non-communicable diseases during the COVID-19 pandemic in Ibadan, Nigeria: a qualitative study.
    Ojewale LY; Mukumbang FC
    BMC Health Serv Res; 2023 Nov; 23(1):1231. PubMed ID: 37946244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Layering and scaling up chronic non-communicable disease care on existing HIV care systems and acute care settings in Kenya: a cost and budget impact analysis.
    Osetinsky B; Mwangi A; Pastakia S; Wilson-Barthes M; Kimetto J; Rono K; Laktabai J; Galárraga O
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25496. PubMed ID: 32562355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs of inappropriate referral pathways in inpatient care for three major noncommunicable diseases in Mongolia: a national registry-based analysis.
    Tuvdendorj A; Dechinkhorloo O; Dorjsuren B; Buskens E; Feenstra T
    BMC Health Serv Res; 2021 Nov; 21(1):1280. PubMed ID: 34838017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of epilepsy care in a Nigerian tertiary hospital.
    Sanya EO; Kolo PM; Adekeye A; Mustapha K; Ademiluyi BA; Ajayi K
    Niger Postgrad Med J; 2013 Dec; 20(4):266-71. PubMed ID: 24633267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Financial Impact of Orthopaedic Sequelae of Intravenous Drug Use on Urban Tertiary-care Centers?
    Dwivedi N; Breslin MA; McDermott A; Lin S; Vallier HA; Tornetta P
    Clin Orthop Relat Res; 2020 Oct; 478(10):2202-2212. PubMed ID: 32667752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.